標題: Titlebook: Cell Therapy Against Cerebral Stroke; Comprehensive Review Kiyohiro Houkin,Koji Abe,Satoshi Kuroda Book 2017 Springer Japan KK 2017 Cell Tr [打印本頁] 作者: ATE 時間: 2025-3-21 16:54
書目名稱Cell Therapy Against Cerebral Stroke影響因子(影響力)
書目名稱Cell Therapy Against Cerebral Stroke影響因子(影響力)學科排名
書目名稱Cell Therapy Against Cerebral Stroke網(wǎng)絡公開度
書目名稱Cell Therapy Against Cerebral Stroke網(wǎng)絡公開度學科排名
書目名稱Cell Therapy Against Cerebral Stroke被引頻次
書目名稱Cell Therapy Against Cerebral Stroke被引頻次學科排名
書目名稱Cell Therapy Against Cerebral Stroke年度引用
書目名稱Cell Therapy Against Cerebral Stroke年度引用學科排名
書目名稱Cell Therapy Against Cerebral Stroke讀者反饋
書目名稱Cell Therapy Against Cerebral Stroke讀者反饋學科排名
作者: 起皺紋 時間: 2025-3-21 21:17
cal trials.Written by experts with considerable personal exp.This book presents comprehensive reviews for both translational research and clinical trials on cell therapy for stroke..Cerebral stroke is still a leading cause of death and disability. However, despite intensive research, few treatment o作者: 雜役 時間: 2025-3-22 01:00
Are operating systems at RISC?,fic transcriptional factor with a viral vector can change the fate of endogenous glial cells to neuronal cells in vivo. In this chapter, we discuss the advantages, issues, and possibility for clinical application of these reprogramming methods for cell transplantation/replacement therapy.作者: 鉤針織物 時間: 2025-3-22 07:47 作者: 議程 時間: 2025-3-22 10:23
Route, Cell Dose, and Timingication of cell-based therapy, but there are not so many studies that scientifically determine the most favorable protocol even in animal experiments. Here, we will review and summarize the current experimental results focusing on the unsolved questions, optimal transplantation route, transplantation cell dose, and transplantation timings.作者: 團結 時間: 2025-3-22 16:22 作者: 團結 時間: 2025-3-22 20:39 作者: GULF 時間: 2025-3-22 23:13
Cell Therapy for Ischemic Stroke with Bone Marrow Stromal Cellsnal recovery through multiple mechanisms, including neuroprotection, inflammatory modulation, cell fusion, and neural differentiation. On the other hands, Muse cells may promote functional recovery after ischemic stroke by reorganizing the infarct brain.作者: Conduit 時間: 2025-3-23 02:36
Book 2017he authors, who are experts in the field of neurosurgery, review and discuss optimal cell sources and various issues involved in translational research; further, they outline ongoing clinical trials in Japan..作者: Deject 時間: 2025-3-23 09:21 作者: 歪曲道理 時間: 2025-3-23 10:08
Optimization of linear systems,er, we review Stem cell Therapeutics as an Emerging Paradigm in Stroke (STEPS) group and the guidelines for the development of cell therapy for stroke in the United States as well as introduce the development of new guidelines in Japan. These guidelines are expected to encourage the development of cell therapy for stroke management.作者: transient-pain 時間: 2025-3-23 15:02 作者: construct 時間: 2025-3-23 20:41
Arthur I. Karshmer,James N. Thomasent. Therefore, in this chapter, the conventional cell culture methods employed for cell preparation (isolation, expansion, and/or derivation) are discussed, with a particular focus on each of the cell types employed in clinical trials of cell therapy against cerebral stroke.作者: Gullible 時間: 2025-3-24 01:39 作者: idiopathic 時間: 2025-3-24 03:51 作者: 圓桶 時間: 2025-3-24 09:55
Neural Stem Cells/Neuronal Progenitor Cellsfor stroke. Additionally, the activation of endogenous neural stem/progenitor cells has recently been employed for stroke treatment. This review provides an introduction to neural stem/progenitor cells and briefly describes some advances in neural stem cell transplantation for stroke.作者: transdermal 時間: 2025-3-24 11:18
Cell Cultureent. Therefore, in this chapter, the conventional cell culture methods employed for cell preparation (isolation, expansion, and/or derivation) are discussed, with a particular focus on each of the cell types employed in clinical trials of cell therapy against cerebral stroke.作者: 抵制 時間: 2025-3-24 16:49 作者: perpetual 時間: 2025-3-24 22:56
Mesenchymal Stem Cells. Here, we review the reparative and protective properties of infused MSCs in stroke models, describe initial human studies on intravenous infusion of MSC in stroke, and provide a perspective on prospects for future progress with MSCs.作者: echnic 時間: 2025-3-25 01:19 作者: Adenocarcinoma 時間: 2025-3-25 06:16 作者: Fortuitous 時間: 2025-3-25 08:04 作者: instulate 時間: 2025-3-25 15:19
http://image.papertrans.cn/c/image/222888.jpg作者: 苦惱 時間: 2025-3-25 16:05
Session three: Discussion summary,rived mononuclear cells (MNCs), a source of stem cells, contain populations of lymphocytes, mesenchymal and hematopoietic stem cells, and hematopoietic and endothelial progenitor cells. They can be rapidly harvested from the bone marrow, separated, isolated, and then returned back into the animal or作者: intercede 時間: 2025-3-25 21:30
Session one: Discussion summary,bone marrow stromal cells (BMSCs) and multilineage-differentiating stress-enduring (Muse) cells. They can be easily isolated from the patients themselves and transplanted into them without any ethical and immunological problem. Animal experiments have shown that direct transplantation of these adult作者: doxazosin 時間: 2025-3-26 01:57
Arthur I. Karshmer,James N. Thomasndrocytes. These cells can be derived from several sources, including embryonic stem cells and fetal tissue. NSCs have been found to exist not only in the developing brain but also in the mature mammalian brain. NSCs were initially cultured as floating neurospheres in the presence of epidermal growt作者: 艱苦地移動 時間: 2025-3-26 07:07
Are operating systems at RISC?,ods have shown that somatic cells can be directly reprogrammed to various kinds of neuronal cells directly. Moreover, overexpression of a neuron-specific transcriptional factor with a viral vector can change the fate of endogenous glial cells to neuronal cells in vivo. In this chapter, we discuss th作者: opprobrious 時間: 2025-3-26 11:47
Arthur I. Karshmer,James N. Thomas cells are produced under GMP conditions, chemically defined conditions and a controlled environment would be ensured. However, such practices do not specify the use of animal-derived or xenogeneic recombinant supplements, which might raise some concern for clinical-grade cell preparations. At the v作者: MEN 時間: 2025-3-26 13:59 作者: grounded 時間: 2025-3-26 20:15 作者: 斜谷 時間: 2025-3-26 21:25 作者: 學術討論會 時間: 2025-3-27 03:01
Susanne Albers,Jeffery Westbrookrebral stroke. However, there are several concerns to be resolved before clinical application of cell therapy for CNS disorders. The issues include the development of imaging techniques to monitor the response of the host CNS. It would be essential to establish functional bio-imaging technique seria作者: 小母馬 時間: 2025-3-27 07:39 作者: 織物 時間: 2025-3-27 12:38
Constructing optimal feedback controls,sing results. We previously demonstrated that therapeutic angiogenesis is essential for neurogenesis after stroke and that intravenous administration of hematopoietic stem cells improves functional recovery through enhanced angiogenesis in an experimental stroke model. Based on these observations, w作者: PHONE 時間: 2025-3-27 17:19
Optimization of linear systems,ctional improvements in animal models including cerebral stroke and spinal cord injury. Suggested mechanisms may include neuroprotection, angiogenesis, induction of axonal sprouting, and remyelination..Therapeutic effects have been reported in animal models of stroke after intravenous infusion of hu作者: 沒花的是打擾 時間: 2025-3-27 19:39 作者: 宣誓書 時間: 2025-3-28 00:11
Cell Therapy for Ischemic Stroke with Bone Marrow Stromal Cellsbone marrow stromal cells (BMSCs) and multilineage-differentiating stress-enduring (Muse) cells. They can be easily isolated from the patients themselves and transplanted into them without any ethical and immunological problem. Animal experiments have shown that direct transplantation of these adult作者: Inveterate 時間: 2025-3-28 02:38 作者: hegemony 時間: 2025-3-28 09:31 作者: 抗原 時間: 2025-3-28 11:49 作者: 全能 時間: 2025-3-28 14:40 作者: integrated 時間: 2025-3-28 21:27 作者: AGGER 時間: 2025-3-29 01:26
In Vivo Cell Tracking Techniques for Applications in Central Nervous System Disorderscell therapy, and several clinical studies have already been initiated worldwide. Although these results are encouraging, several problems remain, including elucidating the therapeutic mechanisms, treatment timing, optimal cell dose, type of cells, and cell delivery route. For further optimization o作者: Deject 時間: 2025-3-29 04:36
Functional Bio-imagingrebral stroke. However, there are several concerns to be resolved before clinical application of cell therapy for CNS disorders. The issues include the development of imaging techniques to monitor the response of the host CNS. It would be essential to establish functional bio-imaging technique seria作者: CRATE 時間: 2025-3-29 08:21 作者: 捏造 時間: 2025-3-29 11:47 作者: Etching 時間: 2025-3-29 17:26 作者: figure 時間: 2025-3-29 21:55 作者: 樂器演奏者 時間: 2025-3-30 01:07
https://doi.org/10.1007/BFb0029350s optimized for central nervous system cells or graft cells help promote survival, migration, and differentiation of grafted cells and contribute to the improvement of neurological function after transplantation. Biomaterials should be further studied to improve safety and efficacy.作者: 藕床生厭倦 時間: 2025-3-30 05:18
On-Line Algorithms in Machine Learning,chnique’s characteristics is crucial for successful in vivo imaging. In this chapter, we present a literature survey of cell tracking techniques used in clinical settings and laboratories and introduce recent advances in this field.作者: 有惡意 時間: 2025-3-30 11:48
Susanne Albers,Jeffery Westbrookf .I-IMZ in the infarct brain of the living rodents longitudinally and noninvasively. Furthermore, we serially assessed local glucose metabolism in the rats subjected to permanent MCA occlusion and found that BMSC transplantation significantly enhances the recovery in the peri-infarct area, using sm作者: 連系 時間: 2025-3-30 14:15
